To assess the efficacy and safety of retrocorneal membrane interception (RMI)-enhanced penetrating canaloplasty in glaucoma secondary to iridocorneal endothelial syndrome (GS-ICE) with open angle or small peripheral anterior synechiae (PAS). A series of 13 patients (13 eyes) with GS-ICE and uncontrolled intraocular pressure (IOP) underwent RMI-enhanced penetrating canaloplasty from March 2019 to October 2020. The patients were followed up at one week, 1month, 3months, 6months, and 12months, postoperatively. The main outcome measure was surgical success, which was defined as an IOP ≤ 18mmHg or ≤ 21mmHg, with glaucoma medications (qualified success), or without glaucoma medications (complete success). Secondary outcome measures were IOP, medication usage, and surgical complications. Among the 13 GS-ICE eyes, 12 (92%) achieved qualified success and 10 (77%) achieved complete success at 12months postoperatively. The mean IOP decreased from 36.41 ± 8.92mmHg on 3.0 (IQR 0.5) medications before surgery to 17.09 ± 7.71mmHg (p = 0.0004) on 0.0 (IQR 0.5) medications (p = 0.0004) at 12months after surgery. Transient hypotony (38%) and hyphema (38%) were the most common complications. RMI-enhanced penetrating canaloplasty appears effective and safe in treating GS-ICE with open angle or small PAS up to one year of follow up.
Read full abstract